Compare Marvel Biosciences Corp. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 14 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.53
38.50%
-3.51
Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2026)
Net Profit:
0 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
21.88%
0%
21.88%
6 Months
34.48%
0%
34.48%
1 Year
62.5%
0%
62.5%
2 Years
77.27%
0%
77.27%
3 Years
116.67%
0%
116.67%
4 Years
95.0%
0%
95.0%
5 Years
-2.5%
0%
-2.5%
Marvel Biosciences Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-181.52%
EBIT to Interest (avg)
-1.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-3.51
EV to EBIT
-11.30
EV to EBITDA
-11.30
EV to Capital Employed
-8.55
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Apr'26 - YoY
Apr'26
Apr'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.40
-0.30
-33.33%
Interest
0.00
0.00
Exceptional Items
0.40
0.00
Consolidate Net Profit
0.40
-0.30
233.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Apr 2026 is 0.00% vs 0.00% in Apr 2025
Consolidated Net Profit
YoY Growth in quarter ended Apr 2026 is 233.33% vs 0.00% in Apr 2025
Annual Results Snapshot (Consolidated) - Jul'25
Jul'25
Jul'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.60
-1.30
-23.08%
Interest
0.30
0.10
200.00%
Exceptional Items
-0.60
-0.20
-200.00%
Consolidate Net Profit
-2.20
-1.70
-29.41%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in year ended Jul 2025 is 0.00% vs 0.00% in Jul 2024
Consolidated Net Profit
YoY Growth in year ended Jul 2025 is -29.41% vs 26.09% in Jul 2024
About Marvel Biosciences Corp. 
Marvel Biosciences Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






